En_CXCR4, En_S100A9, and En_PPP1R1B were specifically highly expressed in the angiogenic group, suggesting that these marker genes may be new targets for anti-angiogenic therapy and forebode breast cancer prognosis in the future. Here, CXCR4 is linked to breast carcinoma.